Diseases · Entity Annotation Prototype (beta)

3articles mentioning diseases

4disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: extensive-stage small cell lung cancer ×

extensive-stage small cell lung cancer

This disease is selected. Its supporting articles are shown below.

Extensive-stage small cell lung cancer3

Articles mentioning extensive-stage small cell lung cancer

3 articles · page 1 of 1

409 Real-world outcomes for patients with extensive-stage small cell lung cancer treated with chemo-immunotherapy in the veterans affair system

jitc · abstract · 2025-11-04 · 2 matching annotations

96.8%

extensive-stage small cell lung cancer extensive-stage small-cell lung cancer ES-SCLC durvalumab atezolizumab platinum-etoposide tremelimumab immunotherapy

…uszko R, Sugawara S, et al. Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the phase III IMpower133 study and…

1118 Deep learning serial CT imaging biomarker for predicting overall survival: a real-world validation in multiple indications of advanced solid tumors treated with immune checkpoint inhibitors

jitc · abstract · 2025-11-04 · 1 matching annotations

84.5%

metastatic melanoma aNSCLC ES-SCLC advanced non-small cell lung cancer kidney cancer extensive-stage small cell lung cancer melanoma RCC skin cancers metastatic renal cell carcinoma+1 more

…for all indications (A), metastatic RCC and kidney cancers (B), metastatic melanoma and skin cancers (C), and extensive-stage SCLC (D). Predetermin…

Durable response to a second course of immunotherapy in a long-term survivor with relapsed small cell lung cancer

bmjcr · abstract · 2025-08-25 · 1 matching annotations

77.6%

ES-SCLC extensive-stage small cell lung cancer Chemoimmunotherapy CIT single-agent immunotherapy

…lapse while off therapy. Here, we are presenting a patient with ES-SCLC, who stopped treatment at 2 years, with disease relapse shortly…